Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Disease Models & Mechanisms|August 1, 2025
Understanding Duchenne muscular dystrophy-associated brain pathologyMinou A T Verhaeg, Rosanne Govaarts, Maaike van Putten
Clinical Neurophysiology Practice|July 29, 2025
Novel approaches to EEG and MEG in motor neurone disease: IFCN Handbook ChapterStefan Dukic, Rosanne Govaarts, Arjan Hillebrand, et al.
Journal of Neuromuscular Diseases|March 29, 2025
Signs and symptoms of carriers of non-<i>DMD</i> X-linked neuromuscular diseases: A scoping reviewJob Simons, Amanda Dekker, Rosanne Govaarts, et al.
Journal of Neurology|February 6, 2021
Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screenEmma Beeldman, Rosanne Govaarts, Marianne de Visser, et al.
Neuromuscular Disorders : NMD|November 10, 2024
Genotype and corticosteroid treatment are distinctively associated with gray matter characteristics in patients with Duchenne muscular dystrophySam Geuens, Jeroen Van Dessel, Hermien E Kan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 14, 2018
The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysisEmma Beeldman, Joost Raaphorst, Michelle Klein Twennaar, et al.
NMR in Biomedicine|July 15, 2024
Probing diffusion of water and metabolites to assess white matter microstructure in Duchenne muscular dystrophyRosanne Govaarts, Nathalie Doorenweerd, Chloé F Najac, et al.
Annals of Clinical and Translational Neurology|October 12, 2023
Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophySam Geuens, Jeroen Van Dessel, Rosanne Govaarts, et al.
Network Neuroscience (Cambridge, Mass.)|July 24, 2025
Longitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment-An exploratory studyRosanne Govaarts, Elliz P Scheijbeler, Emma Beeldman, et al.
Journal of Neurology|May 15, 2026
Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activationHanneke M J Slaghekke, Rosanne Govaarts, Lucia Mesarosova, et al.
Pageof 2